Maturation of hemopoietic cells
US5246699A · kind A · utility
17Cited by
5References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 30, 1991 |
| Grant date | Sep 21, 1993 |
| Priority date | — |
| Expiry date | Dec 30, 2011 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/975
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention concerns the use of IgE-binding factor (IgE-bf) for the stimulation of the maturation, i.e. of the differentiation and proliferation, of myeloid precursor cells in context with interleukin-1 (IL-1). The invention further concerns a a pharmaceutical preparation comprising IgE-bf either alone or in combination with IL-1 for the treatment or prevention of diseases by stimulating the maturation of myeloid precursor cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.